Literature DB >> 10934294

Serum HDL cholesterol concentration in patients with squamous cell and small cell lung cancer.

K Siemianowicz1, J Gminski, M Stajszczyk, W Wojakowski, M Goss, M Machalski, A Telega, K Brulinski, H Magiera-Molendowska.   

Abstract

Cancer patients often present altered serum lipid profile including changes of HDL cholesterol level. The aim of our work was to evaluate serum level of HDL cholesterol in patients with squamous cell and small cell lung cancer and its dependence on histological type and clinical stage of lung cancer. Fasting serum level of HDL cholesterol was analysed in 135 patients with newly diagnosed lung cancer and compared to a control group of healthy men. All lung cancer patients, as well as subgroups of squamous cell and small cell lung cancer had statistically significantly lower HDL cholesterol concentration than controls. There were no statistically significant differences of HDL cholesterol level between the histological types or between clinical stages of each histological type of lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10934294     DOI: 10.3892/ijmm.6.3.307

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  18 in total

1.  HDL-cholesterol and the incidence of lung cancer in the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Anna M Kucharska-Newton; Wayne D Rosamond; Jane C Schroeder; Ann Marie McNeill; Josef Coresh; Aaron R Folsom
Journal:  Lung Cancer       Date:  2008-03-14       Impact factor: 5.705

2.  Cryptotanshinone inhibits lung tumor growth by increasing CD4+ T cell cytotoxicity through activation of the JAK2/STAT4 pathway.

Authors:  Yonghong Man; Le Yang; Dongxian Zhang; Yongyi Bi
Journal:  Oncol Lett       Date:  2016-09-12       Impact factor: 2.967

3.  Cholesterol esters as growth regulators of lymphocytic leukaemia cells.

Authors:  M F Mulas; C Abete; D Pulisci; A Pani; B Massidda; S Dessì; A Mandas
Journal:  Cell Prolif       Date:  2011-06-06       Impact factor: 6.831

4.  Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer.

Authors:  Jiyoung Ahn; Unhee Lim; Stephanie J Weinstein; Arthur Schatzkin; Richard B Hayes; Jarmo Virtamo; Demetrius Albanes
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-11-03       Impact factor: 4.254

5.  Lipid biomarkers and long-term risk of cancer in the Women's Health Study.

Authors:  Paulette D Chandler; Yiqing Song; Jennifer Lin; Shumin Zhang; Howard D Sesso; Samia Mora; Edward L Giovannucci; Kathryn E Rexrode; M Vinayaga Moorthy; Chunying Li; Paul M Ridker; I-Min Lee; JoAnn E Manson; Julie E Buring; Lu Wang
Journal:  Am J Clin Nutr       Date:  2016-04-20       Impact factor: 7.045

6.  Serum 8-isoprostane levels and paraoxonase 1 activity in patients with stage I multiple myeloma.

Authors:  Yousef Faridvand; Ali Eishi Oskuyi; Mohammad-Hassan Khadem-Ansari
Journal:  Redox Rep       Date:  2016-02-26       Impact factor: 4.412

7.  The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.

Authors:  Donovan McGrowder; Cliff Riley; Errol Y St A Morrison; Lorenzo Gordon
Journal:  Cholesterol       Date:  2010-12-23

8.  Association between metabolic abnormalities and HBV related hepatocelluar carcinoma in Chinese: a cross-sectional study.

Authors:  Jinyan Zhao; Yunpeng Zhao; Hao Wang; Xing Gu; Jun Ji; Chunfang Gao
Journal:  Nutr J       Date:  2011-05-15       Impact factor: 3.271

9.  Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.

Authors:  Chunfang Zhang; Luping Yu; Tao Xu; Yichang Hao; Xiaowei Zhang; Zhenhua Liu; Yunbei Xiao; Xiaofeng Wang; Qiang Zeng
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

Review 10.  Influence of liver cancer on lipid and lipoprotein metabolism.

Authors:  Jingting Jiang; Peter Nilsson-Ehle; Ning Xu
Journal:  Lipids Health Dis       Date:  2006-03-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.